U
ENZ

UBS’s Enzo Biochem, Inc. ENZ Stock Holding History

UBS’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$26K Sell
5,000
-5,000
-50% -$26.7K ﹤0.01% 7670
2014
Q2 		$53K Buy
10,000
+2,500
+33% +$10.8K ﹤0.01% 6778
2014
Q1 		$31K Buy
7,500
+5,500
+275% +$18.9K ﹤0.01% 7501
2013
Q4 		$6K Sell
2,000
-500
-20% -$1.24K ﹤0.01% 9455
2013
Q3 		$6K Buy
2,500
+700
+39% +$1.66K ﹤0.01% 9291
2013
Q2 		$4K Buy
+1,800
New +$3.97K ﹤0.01% 9450

Other funds holding ENZ

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return

UBS's ENZ Position: Q3 2014 in Review

UBS reduced its Enzo Biochem, Inc. (ENZ) stake by 2.2% in Q3 2014, selling an estimated $3.97K and leaving 32,366 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #5387.

UBS first reported a position in ENZ in Q2 2013 and has held it in 6 quarters since. The position peaked at $174K in Q2 2014. 92 funds tracked by Wall St. Rank hold ENZ as of Q3 2014.

  • UBS held 32,366 shares of Enzo Biochem, Inc. worth $167K as of Q3 2014.
  • UBS sold 744 Enzo Biochem, Inc. shares in Q3 2014, an estimated $3.97K.
  • Enzo Biochem, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5387 holding.
  • UBS first reported a position in Enzo Biochem, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Enzo Biochem, Inc. position peaked at $174K in Q2 2014.
  • 92 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.